Share of pharmaceutical sales to GDP Thailand 2017-2024

In 2018, the sales of pharmaceuticals in Thailand accounted for a 1.08 percent share of Thailand's GDP. This value was also forecasted to slightly increase over the next years, reaching 1.1 percent by 2024. The Thai pharmaceutical market grew by 4.5 percent per year on average, and it was the second largest pharmaceutical market in Southeast Asia in that year. The domestic pharmaceutical production Although most of pharmaceuticals are produced in developed countries, Thailand still houses 144 pharmaceutical production plants that meet the universal standard. Generally, the main purpose of pharmaceutical production in Thailand is for the domestic market. Only a small share of pharmaceuticals produced in Thailand were exported. Most of the raw ingredients for drug manufacturing were imported, with Germany being the largest market for pharmaceutical imports to Thailand. The pharmaceutical distribution in Thailand Since the Universal Health Coverage scheme provides every public and state enterprise employee in Thailand with healthcare and pharmaceutical accessibility, public hospitals became the main channel for pharmaceutical distribution, accounting for more than half of the total drugs distributed in the country. However, patients with mild ailments such as cough or flu preferred to go to pharmacies to get their medicines.

2018年，泰国药品销售额占泰国国内生产总值（GDP）的1.08%。此数值预计在未来几年内略有上升，预计到2024年将达到1.1%。泰国药品市场以每年平均4.5%的速度增长，当年成为东南亚第二大药品市场。尽管大部分药品由发达国家生产，但泰国仍拥有144家符合国际通用标准的药品生产企业。通常，泰国药品生产的主要目的是满足国内市场需求，出口份额相对较小。制药原料多依赖进口，其中德国是泰国药品进口的最大市场。在泰国，药品分销主要由公共医疗体系承担，由于全民健康覆盖计划为泰国所有公立和国有企业员工提供医疗和药品的可及性，公立医院成为药品分销的主要渠道，占总分销药品量的一半以上。然而，对于轻微病症如咳嗽或流感等患者，他们更倾向于前往药店购买药品。